Compare AVTR & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTR | DLB |
|---|---|---|
| Founded | 1904 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Multi-Sector Companies |
| Sector | Industrials | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 6.4B |
| IPO Year | 2019 | 2005 |
| Metric | AVTR | DLB |
|---|---|---|
| Price | $11.47 | $64.34 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 5 |
| Target Price | $14.86 | ★ $93.60 |
| AVG Volume (30 Days) | ★ 9.4M | 591.2K |
| Earning Date | 02-06-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 2.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.62 |
| Revenue | ★ $6,575,200,000.00 | $1,349,130,000.00 |
| Revenue This Year | N/A | $5.03 |
| Revenue Next Year | $0.05 | $4.02 |
| P/E Ratio | ★ N/A | $24.51 |
| Revenue Growth | N/A | ★ 5.92 |
| 52 Week Low | $10.62 | $64.02 |
| 52 Week High | $23.32 | $89.66 |
| Indicator | AVTR | DLB |
|---|---|---|
| Relative Strength Index (RSI) | 51.23 | 34.30 |
| Support Level | $11.08 | $65.96 |
| Resistance Level | $11.53 | $66.34 |
| Average True Range (ATR) | 0.31 | 1.00 |
| MACD | 0.08 | -0.24 |
| Stochastic Oscillator | 81.02 | 0.00 |
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.